rs367860281
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_014009.4(FOXP3):c.984G>A(p.Met328Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000323 in 1,207,149 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 17 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014009.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXP3 | NM_014009.4 | c.984G>A | p.Met328Ile | missense_variant | 10/12 | ENST00000376207.10 | NP_054728.2 | |
FOXP3 | NM_001114377.2 | c.879G>A | p.Met293Ile | missense_variant | 9/11 | NP_001107849.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXP3 | ENST00000376207.10 | c.984G>A | p.Met328Ile | missense_variant | 10/12 | 1 | NM_014009.4 | ENSP00000365380.4 |
Frequencies
GnomAD3 genomes AF: 0.0000631 AC: 7AN: 110862Hom.: 0 Cov.: 22 AF XY: 0.0000302 AC XY: 1AN XY: 33104
GnomAD3 exomes AF: 0.0000447 AC: 8AN: 178800Hom.: 0 AF XY: 0.0000313 AC XY: 2AN XY: 63800
GnomAD4 exome AF: 0.0000292 AC: 32AN: 1096287Hom.: 0 Cov.: 29 AF XY: 0.0000442 AC XY: 16AN XY: 361793
GnomAD4 genome AF: 0.0000631 AC: 7AN: 110862Hom.: 0 Cov.: 22 AF XY: 0.0000302 AC XY: 1AN XY: 33104
ClinVar
Submissions by phenotype
Insulin-dependent diabetes mellitus secretory diarrhea syndrome Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 18, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 14, 2022 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 17, 2020 | DNA sequence analysis of the FOXP3 gene demonstrated a sequence change, c.984G>A, in exon 10 that results in an amino acid change, p.Met328Ile. This sequence change does not appear to have been previously described in patients with FOXP3-related disorders. It has been described in the gnomAD database with a low population frequency of 0.005% (dbSNP rs367860281). The p.Met328Ile change affects a highly conserved amino acid residue of the FOXP3 protein. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Met328Ile substitution. Due to these contrasting evidences and the lack of functional study, the clinical significance of the p.Met328Ile change remains unknown at this time. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at